HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses
about
Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responsesThe role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases.Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic ControllersDifferences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapyMucosal immunity in human and simian immunodeficiency lentivirus infectionsLow-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controllerCharacterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage.Evaluating cellular polyfunctionality with a novel polyfunctionality index.Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.A small set of succinct signature patterns distinguishes Chinese and non-Chinese HIV-1 genomes.Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues.Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.Vaginal type-II mucosa is an inductive site for primary CD8⁺ T-cell mucosal immunity.Characterization of an effective CTL response against HIV and SIV infections.Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions.In vitro sensitization of T cells with DC-associated/delivered HIV constructs can induce a polyfunctional CTL response, memory T-cell response, and virus suppressionHigher Frequency of NK and CD4+ T-Cells in Mucosa and Potent Cytotoxic Response in HIV Controllers.HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost.Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccineHost factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.Public T cell receptors confer high-avidity CD4 responses to HIV controllersA Recombinant Adenovirus Encoding Multiple HIV-1 Epitopes Induces Stronger CD4(+) T cell Responses than a DNA Vaccine in Mice.Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine.Mucosal immunity in HIV controllers: the right place at the right time.HIV-specific CD4 T cells and immune control of viral replication.HIV controllers: a multifactorial phenotype of spontaneous viral suppression.Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.HIV controllers: a genetically determined or inducible phenotype?Unravelling the mechanisms of durable control of HIV-1.
P2860
Q26995220-9DDB0B6E-7594-4442-B6AB-C5AF53E3E194Q28742853-B1554D67-A3B3-4166-A284-6C10B2C950B5Q30241539-BE24B2F0-6C6A-4833-9217-BA5A3CE33F29Q30362489-757A7FF8-C7B0-423A-8C82-C23450589166Q33611645-762383C9-584B-4B49-929D-701F6327FFC2Q33763297-E7A5472D-7707-47E9-A4BD-9DEC84A99BAEQ33828507-68D288AF-88AC-48FB-BF09-D63ED4508F98Q33865785-FBF4D282-F67D-40EA-8EF0-2165B9CA4383Q34131265-5E802482-D376-4505-A818-57534FBEA316Q34182086-5764A395-D9ED-436F-93D3-388BEEAC3C9AQ34335751-9CA29F0E-0066-4AE0-8C86-7D0E83149D11Q34364864-3CD9BCCF-DAEC-4B69-B413-7C95D0DB9FD8Q34428561-6AEAC042-C251-4883-A7F7-506F37F544BBQ34634310-2F9C98D2-103B-4ED9-AEBE-CDA70B005041Q34988818-86671ECA-51CE-42F4-9AD1-FF3DA56869A7Q35018065-75208B2B-5EF0-4D9B-B6E0-5BD4E3886ABCQ35142356-FFFAAF87-A0D6-40E0-96E6-768E555C8867Q35250925-5FA79DD8-7B39-4900-970F-E19E9A8C9C3BQ35363011-16BA957A-40DE-4151-AF89-BE6C833261EEQ35370381-F512BBF8-A2C5-49A3-BF5F-0E63391EA39AQ35558823-2020D6BC-4357-45C2-9F49-00CAF865EE54Q35731441-CF26DE92-2F9C-4177-A558-FB1F621D706CQ35751335-5055BCA6-60E7-488C-96C8-D092D4D75278Q35883997-427026F4-D727-43A3-BB28-41966D9899CBQ36010933-2897355A-2EF0-41B7-9AD5-85DD368D49F9Q36271927-4B8D416B-FF8A-4A9D-95A5-D9C47394A344Q36450329-0724C9FA-E178-4314-93F4-150EC388715BQ36467153-857E8FEF-CE42-44E7-A82A-DAF5E0A258BCQ36547178-483F7152-D7B4-4C56-BFA4-901DCA71BF57Q36759963-B1513380-0676-408B-B62A-D8D306D5B378Q36951735-0163AF63-04C1-4630-829B-78D3A57730B4Q36956883-EACFC444-6C40-49BB-ADD6-AAF82CF552B4Q37607358-640C9D61-AE32-4D31-B0BC-6DD3A7156B5FQ37628515-C32D92B3-D77F-446C-910B-65D97B617434Q37852547-04C4A1DC-9AF9-477B-A82C-F1C5DFB91F7DQ37866624-A845C8B1-9476-4B94-A624-3BE8FF319E56Q37921949-1FBACC68-C37D-4622-B7E3-50BBC9CBF904Q38086432-B9213051-0DC1-4433-A8FA-98B23625ED76Q38114915-651C334A-0038-42B1-B477-D5F137082BC5Q38116710-7043DDC8-54DC-484C-A908-B0E0E8E4E199
P2860
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@ast
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@en
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@nl
type
label
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@ast
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@en
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@nl
prefLabel
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@ast
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@en
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@nl
P2093
P2860
P356
P1433
P1476
HIV controllers with HLA-DRB1* ...... mucosal CD4+ T-cell responses
@en
P2093
April L Ferre
Barbara L Shacklett
Delandy H McConnell
Jeffrey N Martin
Juan C Garcia
Megan M Morris
Peter W Hunt
Richard B Pollard
P2860
P304
11020-11029
P356
10.1128/JVI.00980-10
P407
P577
2010-08-18T00:00:00Z